Date Time
£1.7m project to explore groundbreaking new treatment for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating – and potentially deadly – wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.
Date Time
At Duke, Future of Pathology Lies in AI
Researchers at Duke University have been merging artificial intelligence with health care to improve patient outcomes for the better part of two decades. From making cochlear implants deliver purer sounds to the brain to finding hidden trends within reams of patient data, the field spans a diverse range of niches that are now beginning to make real impacts.
Among these niches, however, there is one in which Duke researchers have always been at the leading edge-image analysis, with a broad team of researchers teaching computers to analyze images to unearth everything from various forms of cancer to biomarkers of Alzheimer’s disease in the retina.
Philips to expand its leadership in patient care management solutions for the hospital with the acquisition of Capsule Technologies, Inc yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
RACGP
GPs in training across Australia are set to examine a variety of critical health issues and work to improve primary care for patients as part of the Royal Australian College of General Practitioners (RACGP) 2021 Academic Post program.
Starting in February, the RACGP’s Academic Post program is a 12-month training term offered to Australian General Practice Training (AGPT) registrars, which aims to promote general practice research. Those who take part in the program need to complete a research project, supported by a university.
This year’s projects range from researching why women in rural Australia have worse survival rates for breast cancer to how GPs can assist patients experiencing domestic violence. The list of 2021 program recipients and research projects is online here.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Non-small cell lung cancer (NSCLC) is currently the most common cancer in the world and is the leading cause of cancer mortality in men and women. Of total lung cancer incident cases, approximately 85% are the NSCLC subtype. NSCLC patients are usually diagnosed in the later stages of the disease, resulting in a poor prognosis. Since the last global market forecast (2015-2025), there have been significant changes in the treatment of patients with advanced disease, particularly in the metastatic setting.
Although NSCLC is still not considered curable, physicians are enthusiastic about the progress being made in this field. New agents provide more durable responses, as demonstrated by improvements in progression-free survival and overall survival. Progress is demonstrated by the introduction of checkpoint inhibitors into the first-line setting and multiple next-generation targeted therapeutics which have dram